IFNG and myocardial infarction: Then, IFN-γ-loaded MSC-EVs were used to treat a mouse MI model in the infarction region, increasing the amount of miRNA-21 and causing decreased fibrosis, reduced apoptosis of cardiomyocytes, and improved cardiac function [152].